Certified by Founder Lodge
AlveoGene
United Kingdom - Oxford UK
START UP
1 Disclosed Funding Rounds $0
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy.
AlveoGene has been created by OSE, Harrington and OCC in partnershi
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 15 ,2023 | Seed | Undisclosed Amount |
Oxford Science Enterprises
Old College Capital
Harrington Discovery Institute at University Hospitals
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Distribusion Technologies | $80,000,000 | (Sep 27, 2024)
Quorum | Undisclosed Amount | (Sep 27, 2024)
Convergence | $12,000,000 | (Sep 27, 2024)
Tetrix | $5,000,000 | (Sep 27, 2024)
AmpUp | $15,000,000 | (Sep 27, 2024)
